However, SMARD1 — just like SMA and ALS — is not exclusively a motor neuron disease; therefore, IGHMBP2 deficits in other tissues not reached by scAAV9-Abt1 delivery remain impacted. Here, IGHMBP2 is linked to amyotrophic lateral sclerosis.